Does sildenafil cause hypotension? Yes, sildenafil can lower blood pressure, though this effect is typically mild in most patients. As a phosphodiesterase type 5 (PDE5) inhibitor, sildenafil causes vasodilation throughout the body's vascular system, resulting in an average reduction of 8–10 mmHg systolic and 5–6 mmHg diastolic blood pressure at standard doses. Whilst generally well tolerated, the risk of clinically significant hypotension increases substantially when combined with nitrates, alpha-blockers, or in patients with pre-existing cardiovascular conditions. Understanding these risks and recognising symptoms ensures safe, effective use of this widely prescribed medication for erectile dysfunction.

Does Sildenafil Cause Hypotension?

Sildenafil can cause hypotension (low blood pressure), though this effect is generally mild in most patients. Sildenafil, commonly known by the brand name Viagra, belongs to a class of medications called phosphodiesterase type 5 (PDE5) inhibitors. It works by blocking the enzyme PDE5, which leads to increased levels of cyclic guanosine monophosphate (cGMP) in smooth muscle cells. This causes vasodilation—the widening of blood vessels—not only in the penis but throughout the body's vascular system.

The vasodilatory effect of sildenafil typically results in a modest reduction in blood pressure. According to the UK Summary of Product Characteristics (SmPC), sildenafil causes an average decrease of approximately 8–10 mmHg in systolic blood pressure and 5–6 mmHg in diastolic blood pressure when taken at standard doses (25–100 mg). For most healthy individuals, this reduction is well tolerated and causes no significant symptoms. The blood pressure-lowering effect usually peaks 1–2 hours after taking the medication, coinciding with maximum plasma concentrations.

In patients on stable antihypertensive therapy (other than alpha-blockers), the additional blood pressure lowering effect is generally modest. However, the risk of clinically significant hypotension increases substantially when sildenafil is combined with certain other medications, particularly nitrates (such as glyceryl trinitrate), nicorandil, or soluble guanylate cyclase stimulators (such as riociguat). The Medicines and Healthcare products Regulatory Agency (MHRA) has issued clear warnings about these interactions. In isolation, sildenafil-induced hypotension is usually transient and self-limiting, but patients with pre-existing cardiovascular conditions, those taking multiple antihypertensive medications, or individuals with baseline low blood pressure may experience more pronounced effects.

Risk Factors for Hypotension with Sildenafil

Several patient-specific and medication-related factors significantly increase the risk of experiencing hypotension when taking sildenafil. The most critical risk factor is concurrent use of nitrate medications, which are commonly prescribed for angina (chest pain). Nitrates work through a similar mechanism to sildenafil by increasing cGMP levels, and when combined, the two medications produce a synergistic effect that can cause severe, potentially life-threatening hypotension. This combination is absolutely contraindicated, and patients must inform their healthcare provider about any nitrate use, including short-acting preparations (glyceryl trinitrate spray or tablets) and long-acting formulations (isosorbide mononitrate). Importantly, nitrates should not be used within at least 24 hours after taking sildenafil.

Alpha-blocker medications, used to treat benign prostatic hyperplasia (BPH) and hypertension, also pose a significant interaction risk. Drugs such as doxazosin, tamsulosin, and alfuzosin can cause additive blood pressure lowering when combined with sildenafil. Patients should be stable on alpha-blocker therapy before starting sildenafil, which should be initiated at the lowest dose (25 mg). With non-selective alpha-blockers like doxazosin, consider spacing doses by several hours to reduce the risk of postural hypotension.

Soluble guanylate cyclase stimulators (such as riociguat) are contraindicated with sildenafil due to the risk of severe hypotension.

Other important risk factors include:

• Pre-existing cardiovascular disease, particularly left ventricular outflow obstruction, severe heart failure, or recent myocardial infarction

• Baseline hypotension (resting blood pressure below 90/50 mmHg)

• Volume depletion or dehydration, which reduces circulating blood volume

• Advanced age (over 65 years), as older patients may have reduced cardiovascular reserve

• Hepatic or severe renal impairment, which affects sildenafil metabolism and clearance

• Concurrent use of CYP3A4 inhibitors such as ritonavir (limit sildenafil to 25 mg in 48 hours), ketoconazole, itraconazole, erythromycin, or clarithromycin, which increase sildenafil plasma concentrations

• Grapefruit juice, which can increase sildenafil levels

While other antihypertensive medications (calcium channel blockers, ACE inhibitors, or diuretics) may cause additional blood pressure lowering, this effect is usually modest in patients on stable therapy.

Symptoms of Low Blood Pressure to Watch For

Recognising the symptoms of hypotension is essential for patients taking sildenafil, as early identification allows for appropriate management and prevents potential complications. The most common symptoms of sildenafil-induced low blood pressure include dizziness and light-headedness, particularly when standing up quickly from a sitting or lying position (orthostatic hypotension). This occurs because the body's normal compensatory mechanisms may be temporarily impaired by the medication's vasodilatory effects.

Patients may experience:

• Dizziness or feeling faint, especially within 1–2 hours of taking sildenafil

• Headache, which is a common side effect of sildenafil

• Flushing (redness and warmth in the face and upper body)

• Weakness or fatigue, particularly with exertion

• Palpitations or awareness of heartbeat, as the heart attempts to compensate for lower blood pressure

• Nausea in some cases

Sildenafil can also cause visual disturbances, including blurred vision or increased sensitivity to light, but these are generally related to the medication's mild inhibition of PDE6 in the retina rather than being symptoms of hypotension.

More severe symptoms warrant immediate medical attention. These include profound dizziness leading to loss of consciousness (syncope), chest pain or tightness, severe shortness of breath, or confusion. Such symptoms may indicate significant cardiovascular compromise and require urgent assessment.

Patients should also seek immediate medical help for these important red flags:

• Prolonged erection lasting more than 4 hours (priapism)

• Sudden vision loss in one or both eyes

• Sudden hearing loss or ringing in the ears

Patients should be advised to sit or lie down immediately if they feel dizzy or faint after taking sildenafil. Remaining well hydrated and avoiding sudden postural changes can help minimise orthostatic symptoms. It is important to note that whilst mild dizziness or headache is relatively common and often resolves without intervention, persistent or severe symptoms should prompt contact with a GP or NHS 111. Patients experiencing chest pain should call 999 immediately, as this may indicate a serious cardiac event rather than simple hypotension.

Safe Use of Sildenafil: Precautions and Contraindications

Safe use of sildenafil requires careful patient selection, appropriate dosing, and awareness of absolute contraindications. Before prescribing sildenafil, healthcare professionals should conduct a thorough cardiovascular assessment, as sexual activity itself carries cardiovascular demands. NICE guidance emphasises that erectile dysfunction may be an early marker of cardiovascular disease, and patients presenting with this complaint should undergo cardiovascular risk assessment.

Absolute contraindications to sildenafil include:

• Concurrent use of nitrates or nitric oxide donors (including nicorandil and amyl nitrite)

• Concurrent use of soluble guanylate cyclase stimulators (such as riociguat)

• Men for whom sexual activity is inadvisable due to cardiovascular status (e.g., unstable angina, severe heart failure)

• Recent stroke or myocardial infarction (within 6 months)

• Severe hypotension (blood pressure below 90/50 mmHg)

• History of non-arteritic anterior ischaemic optic neuropathy (NAION)

• Known hypersensitivity to sildenafil or any excipients

Precautions and dose adjustments are necessary for:

• Patients over 65 years (starting dose 25 mg)

• Those with hepatic impairment of any severity (starting dose 25 mg)

• Severe renal impairment (starting dose 25 mg)

• Patients taking CYP3A4 inhibitors such as erythromycin, clarithromycin, or certain antifungal medications (itraconazole, ketoconazole), which increase sildenafil plasma concentrations

• Patients taking ritonavir (maximum sildenafil dose 25 mg in 48 hours)

Patients should be counselled to:

• Take sildenafil approximately one hour before sexual activity on an empty stomach for optimal absorption

• Never exceed one dose in 24 hours

• Avoid excessive alcohol consumption, which can exacerbate hypotensive effects and impair erectile function

• Stop taking sildenafil and seek immediate medical help if they experience chest pain during sexual activity, priapism (erection lasting >4 hours), or sudden vision or hearing loss

• Inform all healthcare providers about sildenafil use, particularly before any surgical procedures or if nitrates might be needed (nitrates should not be used within at least 24 hours of sildenafil)

Patients should contact their GP if they experience persistent side effects, if the medication is ineffective after several attempts, or if they develop new cardiovascular symptoms. Suspected adverse reactions should be reported via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk). Regular medication reviews ensure continued appropriateness of treatment, particularly as cardiovascular risk factors may change over time. Sildenafil remains a safe and effective treatment for erectile dysfunction when used appropriately in carefully selected patients with proper monitoring and adherence to prescribing guidelines.

Frequently Asked Questions